Astria Therapeutics Inc
(ATXS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,293 | -25,870 | -27,364 | -36,060 | -32,630 |
| Depreciation Amortization | N/A | 119 | 304 | 395 | 202 |
| Accounts payable and accrued liabilities | -211 | 662 | -632 | 77 | 196 |
| Other Working Capital | -1,870 | 762 | -1,934 | 274 | 684 |
| Other Operating Activity | 1,805 | 862 | 2,790 | 2,456 | 1,755 |
| Operating Cash Flow | $-26,569 | $-23,465 | $-26,836 | $-32,858 | $-29,793 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -4,070 | N/A | N/A | N/A | N/A |
| PPE Investments | -12 | 369 | -27 | -407 | -421 |
| Purchase Of Investment | N/A | -70,364 | N/A | -45,539 | N/A |
| Sale Of Investment | N/A | 48,090 | 14,910 | 30,456 | N/A |
| Investing Cash Flow | $-4,082 | $-21,905 | $14,883 | $-15,490 | $-421 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 5,000 |
| Debt Repayment | N/A | -2,848 | -3,333 | -3,333 | -833 |
| Common Stock Issued | 25,620 | 47,143 | 8,059 | 12,497 | 61,835 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 12,324 |
| Financing Cash Flow | $25,620 | $44,295 | $4,726 | $9,164 | $78,326 |
| Beginning Cash Position | 15,407 | 16,482 | 23,709 | 62,780 | 14,668 |
| End Cash Position | 10,376 | 15,407 | 16,482 | 23,596 | 62,780 |
| Net Cash Flow | $-5,031 | $-1,075 | $-7,227 | $-39,184 | $48,112 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,569 | -23,465 | -26,836 | -32,858 | -29,793 |
| Capital Expenditure | -12 | N/A | -57 | -459 | -421 |
| Free Cash Flow | -26,581 | -23,465 | -26,893 | -33,317 | -30,214 |